Clinical Trial Update: Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Clinical Trials [Phase 2]

View source ↗

Summary

This Phase 2 trial update covers a rabies monoclonal antibody-based combination vaccine (CBB-1) being studied in healthy volunteers to assess antibody neutraliz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• Rabies mAb CBB-1 Combination Vaccine (CBB-1 Rabies Monoclonal Antibody Combination Vaccine)

Snippet

Sponsor: Changchun BCHT Biotechnology Co. | Conditions: Rabies Virus Infection | Phase 2 | Status: NOT_YET_RECRUITING